Bristol-Myers Squibb Co (Bristol-Myers Squibb Co) COGS-to-Revenue : 0.25 (As of Mar. 2024)

View and export this data going back to 1990. Start your Free Trial

What is Bristol-Myers Squibb Co COGS-to-Revenue?

Bristol-Myers Squibb Co's Cost of Goods Sold for the three months ended in Mar. 2024 was $2,932.00 Mil. Its Revenue for the three months ended in Mar. 2024 was $11,865.00 Mil.

Bristol-Myers Squibb Co's COGS to Revenue for the three months ended in Mar. 2024 was 0.25.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Bristol-Myers Squibb Co's Gross Margin % for the three months ended in Mar. 2024 was 75.29%.

Bristol-Myers Squibb Co COGS-to-Revenue Historical Data

The historical data trend for Bristol-Myers Squibb Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co COGS-to-Revenue Chart

Bristol-Myers Squibb Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.31

0.28

0.21

0.22

0.24

Bristol-Myers Squibb Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.23	0.26	0.23	0.24	0.25

Bristol-Myers Squibb Co COGS-to-Revenue Calculation

Bristol-Myers Squibb Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	10693	/	45006
	=	0.24

Bristol-Myers Squibb Co's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	2932	/	11865
	=	0.25

Bristol-Myers Squibb Co (NYSE:BMY.R) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Bristol-Myers Squibb Co's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	2932 / 11865
	=	75.29 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Bristol-Myers Squibb Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Bristol-Myers Squibb Co (Bristol-Myers Squibb Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (NYSE:BMY.R) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

BMYMP.PFD:USA BMY:USA BMY:Peru BMY:Mexico 1BMY:Italy BRMd:UK 0R1F:UK BRM:Germany BRM:Germany BRM:Germany BRM:Germany BMYB34:Brazil BMYS:Austria BMY:Argentina

Address

430 East 29th Street, 14th Floor, New York, NY, USA, 10016

Website

https://www.bms.com

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.